Latest Impairment News

SGH Ltd has reported a robust half-year performance for the period ending December 31, 2024, with revenue up 2.2% and net profit soaring 174.5%, underpinned by strong operational segments and strategic acquisitions.

Pilbara Minerals delivers record production and sales at Pilgangoora but faces statutory net losses due to joint venture investments and expansion costs. The company remains optimistic about long-term lithium market prospects.

360 Capital Mortgage REIT (ASX:TCF) reported a robust HY25 performance, highlighting a forecast distribution yield of 10.2% and a successful $8.9 million capital raising that expands its loan portfolio and market presence.

360 Capital Mortgage REIT delivered robust half-year results with a 33% earnings upgrade and a strategic capital raise that lifted its market cap by over a third.

PEXA Group Limited has updated its half-year guidance, flagging a $15 million non-cash impairment and a significant increase in tax expenses due to deferred tax asset derecognition.

Beach Energy Limited has reversed its fortunes with a $222.3 million net profit for H1 FY25, driven by higher production and improved gas prices. The company also announced a fully franked interim dividend of 3.0 cents per share.

Strata Minerals Limited has identified four significant drill targets at its Penny South Gold Project in WA and is set to commence its maiden drilling program in February 2025, signaling a major step forward in its exploration strategy.

Jervois Global Limited has entered a pivotal recapitalization agreement with Millstreet Capital Management, involving a US$145 million equity injection and a pre-packaged Chapter 11 bankruptcy process. The company aims to strengthen its balance sheet and continue operations uninterrupted while preparing for a strategic restart of its nickel-cobalt refinery in Brazil.

Vintage Energy has launched a $2.1 million entitlement offer to fund a targeted production uplift program at its Odin and Vali gas fields, aiming to significantly increase gas output and cash flow in the near term.

Frontier Digital Ventures posts a mixed fourth quarter with overall revenue growth but EBITDA pressures, while advancing a strategic review focused on unlocking shareholder value.

Alterity Therapeutics has reported positive Phase 2 results for ATH434, showing significant slowing of Multiple System Atrophy progression and a favorable safety profile. The trial demonstrated clinical benefits alongside reductions in brain iron accumulation, a key disease driver.

Mineral Commodities Ltd reported a steep net loss of USD 65.1 million for H1 2024, driven by operational disruptions at its Tormin mine and strategic moves including the sale of its Skaland Graphite Project.